Neurosense Therapeutics Ltd. (NRSN)
NASDAQ:NRSN
US Market
Holding NRSN?
Track your performance easily

Neurosense Therapeutics Ltd. (NRSN) Financial Statements

110 Followers

Neurosense Therapeutics Ltd. Financial Overview

Neurosense Therapeutics Ltd.'s market cap is currently ―. The company's EPS TTM is $-0.532; its P/E ratio is -2.50; Neurosense Therapeutics Ltd. is scheduled to report earnings on November 27, 2024, and the estimated EPS forecast is $-0.11. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Sep 22Jun 22Mar 22
Income Statement-
Total Revenue--$ 0.00$ 0.00$ 0.00
Gross Profit-----
EBIT--$ -2.98M$ -3.45M$ -2.69M
EBITDA--$ -2.98M$ -3.45M$ -2.69M
Net Income Common Stockholders--$ -2.99M$ -3.48M$ -2.71M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 2.64M$ 3.58M$ 8.44M$ 10.37M$ 13.74M
Total Assets$ 3.18M$ 7.71M$ 9.23M$ 11.45M$ 14.36M
Total Debt$ 73.00K$ 147.00K$ 173.00K$ 190.00K$ 207.00K
Net Debt$ -2.57M$ -3.44M$ -8.27M$ -10.18M$ -13.53M
Total Liabilities$ 5.05M$ 2.09M$ 1.38M$ 1.62M$ 2.25M
Stockholders Equity$ -1.87M$ 5.62M$ 7.85M$ 9.84M$ 12.11M
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in USD

Neurosense Therapeutics Ltd. Earnings and Revenue History

Neurosense Therapeutics Ltd. Debt to Assets

Neurosense Therapeutics Ltd. Cash Flow

Neurosense Therapeutics Ltd. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis